Kidney protection with canagliflozin: A combined analysis of the randomized CANVAS program and CREDENCE trials.

Vikas S SridharBrendon L NeuenRobert A FletcherApril SleeFernando G AngWally Rapattoni Clare Arnott David Z I CherneyVlado PerkovicDavid C WheelerAdeera Levin

Published in: Diabetes, obesity & metabolism (2023)

These results emphasize a critical role of canagliflozin in kidney protection across a broad spectrum of participants with type 2 diabetes with varying levels of kidney function.

Keyphrases

double blind
open label
quality improvement
placebo controlled
phase iii
phase ii
clinical trial
study protocol